Microbix Biosystems Inc. has seen a modest uptick in its stock performance this week, with key developments shaping investor sentiment.
Microbix Biosystems Inc. (MBX.TO) has witnessed a 5.36% increase in its stock price today, bringing its weekly performance to a positive 1.72%. As the company navigates through its financial landscape, recent announcements and ongoing efforts to stabilize revenues have garnered attention from investors.
Advertisement
Microbix Biosystems Inc.
MBX.TO
MBX.TO
Microbix Biosystems Inc.
WealthAwesomeMarket cap
$43.15M
52W high
$0.33
52W low
$0.21
1W change
+0.00%
Beta
0.54
Analyst Price Targets
Based on analyst covering MBX · as of Sep 17, 2026
Wall Street analysts forecast MBX stock price to rise 29.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.40
+29.0% Upside
Current Price
C$0.31
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MBX's historical volatility
30-Day Vol
52.0%
Annualized
90-Day Vol
47.8%
Annualized
Trend (90d)
-0.0%
Annualized drift
90d Mean
C$0.31
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.31 | C$0.26 – C$0.37 |
| 60 trading days | C$0.31 | C$0.24 – C$0.40 |
| 90 trading days | C$0.31 | C$0.23 – C$0.42 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Microbix continues to focus on rebuilding its revenue streams and addressing past setbacks, which may be critical for potential investors to consider as they evaluate the company's future prospects.
Microbix's stock price closed at C$0.29 with a 1D increase of 5.36%.
The stock has a market cap of approximately C$38.4 million, reflecting its small-cap status within the healthcare sector.
Bull case
The company reported a 17% revenue growth in its latest fiscal quarter, indicating a positive trend in recovery efforts. Analysts are optimistic, with an average target price suggesting a significant upside for investors.
Bear case
Despite the recent uptick, Microbix's profit margin remains negative at -31.7%. The company still faces challenges in achieving profitability, which could deter some investors from getting involved.
Recent Price Action
Microbix Biosystems Inc. (MBX.TO) has experienced a notable 5.36% increase in its stock price today, closing at C$0.29. Over the past week, the stock has risen by 1.72%. Year-to-date, the stock has shown a positive performance with a 22.92% increase, reflecting a recovery trajectory.
Company News and Developments
Advertisement
This week, there were no significant announcements from Microbix. However, the company previously reported its Q3 fiscal 2026 results, highlighting a revenue of $4.1 million and a controlled net loss. This marks a 17% increase in revenue compared to the same quarter last year, showing progress in its efforts to rebuild after setbacks faced in mid-2025.
Technical Picture
From a technical standpoint, Microbix's stock is currently trading near its 50-day moving average of C$0.30, which is 2.4% lower than the current price. The stock is above its 200-day moving average of C$0.26, indicating a positive trend of 13.4%. The 52-week range for the stock has been C$0.21 to C$0.33, with the current price at approximately 71% of that range. The stock's beta of 0.57 suggests lower volatility compared to the overall market, which may appeal to risk-averse investors.
Insider Activity
There were no recent insider activities reported for Microbix Biosystems Inc., which can often be a point of interest for investors looking to gauge insider sentiment.
Price Action Summary
Microbix Biosystems Inc. closed at C$0.29 today, reflecting a 5.36% increase in price. As the company continues to address its financial challenges and rebuild its revenue base, investors may want to keep an eye on future performance and developments.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
